The clinical value of CT and SWI in evaluating the occurrence of CMBs in diabetic patients with hypertension
10.13491/j.issn.1004-714X.2021.04.023
- VernacularTitle:CT和SWI评估糖尿病合并高血压患者发生CMBs临床价值探讨
- Author:
Guanghui HE
1
;
Haiqing ZHANG
2
;
Xinhua LI
3
;
Wenyu DING
3
;
Lei LIU
4
;
Yong ZHANG
3
;
Wen XIONG
3
Author Information
1. Shandong Electric Power Central Hospital, Ji'nan 250012 China.
2. Provincial Hospital Affiliated to Shandong First Medical University, Ji'nan 250021 China.
3. Endocrine and Metabolic Diseases Hospital of Shandong First Medical University, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan 250062 China.
4. The First Affiliated Hospital of Shandong First Medical University, Ji'nan 250031 China.
- Publication Type:SupervisionandManagement/OriginalArticles
- Keywords:
CT;
Susceptibility Weighted Imaging;
Intracerebral Microbleeds;
Diabetes;
Hypertension
- From:
Chinese Journal of Radiological Health
2021;30(4):506-511
- CountryChina
- Language:Chinese
-
Abstract:
Objective With the help of computerized tomography (CT) and susceptibility-weighted imaging (SWI) examinations, to analyze and compare the incidence and the prevalent sites of microbleeds (CMBs) in control group, diabetes group, hypertension group and diabetic hypertension group with intracerebral CMBs. The risk factors for the onset of CMBs also will be explored, in order to provide a basis for the selection of clinical diagnosis and treatment options for CMBs. Methods A collection of 174 non-acute patients in the Department of Neurology of Shandong Electric Power Central Hospital from May 2019 to October 2020, including 101 males and 73 females, aged 45-89 years, with an average age of 72 ± 5 years. Divided into four groups according to disease types: Hypertension with type 2 diabetes group, Hypertension group, Type 2 diabetes group, Control group (no hypertension and type 2 diabetes). All patients underwent CT and MRI SWI sequence scans. The 4 groups of patients were matched in terms of gender and age, excluding the influence of gender and age. The incidence, number and distribution of CMBs in the four groups were counted, and the CT and SWI imaging manifestations of CMBs in the four groups were analyzed and compared. Results CT did not find the incidence of CMBs in the brain of patients. SWI imaging showed that CMBs were detected in 58 of 174 patients (incidence rate 33.3%), and CMBs occurred in 24 cases of diabetes and hypertension group (incidence rate 57.1%). CMBs occurred in 21 cases in the hypertension group (incidence rate 46.7%), 8 cases in the diabetes group (incidence rate 22.2%), and CMBs occurred in 5 cases in the control group (incidence rate 9.8%). The incidence of CMBs in the hypertension group and the diabetes combined with hypertension group was significantly higher than that in the control group (P < 0.05). There was no significant difference in the incidence of CMBs in patients with simple diabetes compared with the control group. Also, there was no significant difference in the incidence of CMBs between the diabetes combined with hypertension group and the simple hypertension group. Conclusion CT did not find the incidence of CMBs in the brains of patients in the non-acute phase. SWI could clearly show the CMBs of the enrolled patients. Diabetes is less likely to cause an increase in CMBs. Hypertension is significantly related to the occurrence of CMBs. CMBs associated with hypertension or/and diabetes are common in the basal ganglia and thalamus, which is different from cerebral amyloid angiopathy, which provides a basis for the choice of clinical treatment options.
